Grant: CIHR Fellowship
University of Toronto
$135,000.00
Large-scale identification of suppressors of human disease genes in yeast
EF 2012-13
Résumé
Mistakes ("mutations") in DNA can cause damage to cells. Often additional DNA mutations can compensate for the harm caused by the first mutation. This process is referred to as genetic suppression. If the initial mutation occurred in a gene involved in human disease, the site of the second mutation (the "suppressor") indicates a potential target for novel drugs. In this research project, we will map these compensation-relations for human disease genes on a large scale. To do this, we will use baker's yeast as a model organism. On a microscopic level, yeast cells provide a model for human cells and, indeed, many genes involved in human diseases have an equivalent yeast gene. After the suppressor genes have been identified in yeast, we will screen a collection of chemicals to identify compounds that mediate a chemical suppression phenotype and therefore likely target the suppressor gene product. Identification of such compounds might lead to the development of new drugs and disease therapies. This type of large-scale suppressor analysis will gain us new insight into compensatory relationships between genes. Additionally, this project should identify possible drug-targets for specific genetic diseases and provide valuable information on the molecular mechanisms underlying these diseases.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
281948
Name
van Leeuwen Jolanda
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Large-scale identification of suppressors of human disease genes in yeast
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Genetic Diseases; Genetic Suppression; Next-Generation Sequencing; Synthetic Genetic Array Mapping; Yeast Genetics
Abstract
Mistakes ("mutations") in DNA can cause damage to cells. Often additional DNA mutations can compensate for the harm caused by the first mutation. This process is referred to as genetic suppression. If the initial mutation occurred in a gene involved in human disease, the site of the second mutation (the "suppressor") indicates a potential target for novel drugs. In this research project, we will map these compensation-relations for human disease genes on a large scale. To do this, we will use baker's yeast as a model organism. On a microscopic level, yeast cells provide a model for human cells and, indeed, many genes involved in human diseases have an equivalent yeast gene. After the suppressor genes have been identified in yeast, we will screen a collection of chemicals to identify compounds that mediate a chemical suppression phenotype and therefore likely target the suppressor gene product. Identification of such compounds might lead to the development of new drugs and disease therapies. This type of large-scale suppressor analysis will gain us new insight into compensatory relationships between genes. Additionally, this project should identify possible drug-targets for specific genetic diseases and provide valuable information on the molecular mechanisms underlying these diseases.
Competitiondate
201302
Approvedterm2
3 yrs 0 mth
Pinamesdelim
van Leeuwen, Jolanda
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~